Skip to main content
. 2022 Nov 9;12:19035. doi: 10.1038/s41598-022-23200-1

Table 1.

Characteristics of LEOSS and UKD patients with CP treatment.

Variable Nr patients Mortality (n/% out of category)
LEOSS UKD LEOSS UKD
Total 156 55 46 23
Age
18–25 years 3 1 0 0
26–35 years 6 1 0 0
36–45 years 12 5 2 (16.7) 0
46–55 years 32 3 6 (18.8) 3 (100)
56–65 years 36 13 11 (30.1) 4 (30.7)
66–75 years 36 15 14 (38.9) 10 (66.7)
76–85 years 25 9 11 (44) 3 (33.3)
 > 85 years 6 8 2 (33.3) 3 (37.5)
Gender
Male 119 34 40 (33.6) 16 (47)
Female 37 21 6 (16.7) 7 (33.3)
BMI
18,5–24,9 kg/m2 35 18 7 (20) 9 (50)
25–29,9 kg/m2 47 18 17 (36.2) 7 (38.9)
30–34,9 kg/m2 31 8 11 (35.5) 2 (25)
 > 34,9 kg/m2 14 5 5 (35.7) 3 (60)
Unknown 29 6 6 (20.7) 2 (33.3)
Stage at diagnosis
Uncomplicated phase 81 14 17 (21) 3 (21.4)
Complicated Phase 45 18 15 (33.3) 6 (33.3)
Critical illness 29 23 14 (48.3) 14 (60.8)
Unknown 1 0
Duration inpatient stay
 ≥ 14 days 119 36 35 (29.4) 14 (38.9)
 < 14 days 36 19 10 (27.8) 9 (47.4)
Missing 1 1 (100)
Duration ICU stay
 < 3 31 2 5 (16.1) 1 (50)
3–15 37 20 15 (40.5) 12 (60)
 > 15 days 77 14 26 (33.8) 7 (50)
Missing 11 0
None 19 3 (15.8)